Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2021-08-25 00:00:00 ET · period of report 2021-08-23 · accession 0001437749-21-021016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-25 | 2021-08-23 | BLFS | Foster Karen A. | Chief Quality Off | M - OptEx | $1.64 | +16.3K | 89.1K | +22% | +$26.8K |
| D | 2021-08-25 | 2021-08-23 | BLFS | Foster Karen A. | Chief Quality Off | S - Sale+OE | $46.54 | -16.3K | 72.8K | -18% | -$760.1K |
| D | 2021-08-25 | 2021-08-23 | BLFS | Foster Karen A. | Chief Quality Off | M - OptEx | $0.00 | -16.3K | 49.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-23 | M | A | 16,332 | $1.64 | 89,109 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-23 | S | D | 16,332 | $46.54 | 72,777 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.4 to $47.02 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-08-23 | M | D | 16,332 | $0.00 | 48,996 | D | $1.64 · — to 2021-12-20 | 16,332 Common Stock | (F3) On December 20, 2016, the reporting person was granted an option to purchase 163,323 shares of common stock which vested in two equal installments on March 8, 2018 and March 8, 2019. |